Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 15,886 | 13,354 | 14,980 | 18,955 | 14,181 |
| Operating Income | -15,886 | -13,354 | -14,980 | -18,955 | -14,181 |
| Other Income | 19 | 13 | 14 | -15 | 53 |
| Pre-tax Income | -15,867 | -13,341 | -14,966 | -18,970 | -14,128 |
| Net Income Continuous | -15,867 | -13,341 | -14,966 | -18,970 | -14,128 |
| Net Income | $-15,867 | $-13,341 | $-14,966 | $-18,970 | $-14,128 |
| EPS Basic Total Ops | -0.73 | -0.62 | -0.69 | -0.88 | -0.65 |
| EPS Basic Continuous Ops | -0.73 | -0.62 | -0.69 | -0.88 | -0.65 |
| EPS Diluted Total Ops | -0.73 | -0.62 | -0.69 | -0.88 | -0.65 |
| EPS Diluted Continuous Ops | -0.73 | -0.62 | -0.69 | -0.88 | -0.65 |
| EPS Diluted Before Non-Recurring Items | -0.73 | -0.62 | -0.69 | -0.88 | -0.65 |
| EBITDA(a) | $-15,723 | $-13,117 | $-14,841 | $-18,776 | $-13,979 |